Memorial Sloan-Kettering Opens Rockefeller Outpatient Pavilion

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 8 No 8
Volume 8
Issue 8

NEW YORK-Memorial Sloan-Kettering Cancer Center’s new Laurance S. Rockefeller Outpatient Pavilion provides advanced programs for outpatient cancer diagnosis and treatment in a calm and beautiful environment. “We believe this facility will serve as a national model for the delivery of outpatient cancer care in the new millennium,” said Paul A. Marks, MD, president and CEO.

NEW YORK—Memorial Sloan-Kettering Cancer Center’s new Laurance S. Rockefeller Outpatient Pavilion provides advanced programs for outpatient cancer diagnosis and treatment in a calm and beautiful environment. “We believe this facility will serve as a national model for the delivery of outpatient cancer care in the new millennium,” said Paul A. Marks, MD, president and CEO.

The 190,000-square-foot facility is located at 53rd Street and Third Avenue in midtown Manhattan. Patient care services include gastrointestinal, genitourinary, gynecology (ovarian and cervical cancer); dermatology, thoracic oncology, clinical immunology, cardiology and pulmonary, radiology, and plastic and reconstructive surgery consultations, as well as pharmacy services, a boutique (see figure), and a conference center.

The physical environment is designed to convey a sense of peace and well-being, and includes several waterfalls, sculptural water gardens in 9 reception areas, and original works of art and poetry.

Other interesting aspects of the Rockefeller Pavilion include: organizing patient care services by specific diseases so that teams of specialists work together on the same floor; creating a technology infrastructure so that medical records and x-rays are tracked electronically and are easily available to members of the disease team; and providing patients with Internet access and a comprehensive patient education program with CD-ROMs.

Laurance S. Rockefeller, for whom the building is named, said: “This extraordinary new facility . . . stands as a symbol of our belief in the healing synergy between medical science and the power of each individual patient’s mind, body, and spirit.” Mr. Rockefeller is honorary co-chairman of the Boards of Overseers and Managers at Memorial Sloan-Kettering.

Recent Videos
Overall survival benefit was significant with complete vs incomplete consolidation therapy, but lost significance when stratified by disease burden.
James Ninia, MD, discussed treatment options for patients with extensive-stage small cell lung cancer undergoing metastasis-directed radiotherapy.
Whole or accelerated partial breast ultra-hypofractionated radiation in older patients with early breast cancer may reduce recurrence with low toxicity.
Ultra-hypofractionated radiation in those 65 years or older with early breast cancer yielded no ipsilateral recurrence after a 10-month follow-up.
The unclear role of hypofractionated radiation in older patients with early breast cancer in prior trials incentivized research for this group.
4 KOLs are featured in this series.
4 KOLs are featured in this series.
A panel of 5 experts on multiple myeloma